With recent news dominated by CRISPR, it is easy to forget that gene editing can be accomplished with other platforms as well. In fact, two of these platforms preceded CRISPR in clinical trials, and at least three are under continued development by big pharma.
Category Archives: Technical
Watch-list of Gene Editing Clinical Trials
So far, only two clinical trials have attempted in vivo gene editing, and more than ten have evaluated ex vivo or cell transplantation approaches.